These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18286727)

  • 1. A nine session manual of motivational enhancement therapy for methamphetamine dependence: adherence and efficacy.
    Galloway GP; Polcin D; Kielstein A; Brown M; Mendelson J
    J Psychoactive Drugs; 2007 Nov; Suppl 4():393-400. PubMed ID: 18286727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence.
    Heinzerling KG; Swanson AN; Kim S; Cederblom L; Moe A; Ling W; Shoptaw S
    Drug Alcohol Depend; 2010 Jun; 109(1-3):20-9. PubMed ID: 20092966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in psychiatric symptoms among persons with methamphetamine dependence predicts changes in severity of drug problems but not frequency of use.
    Polcin DL; Korcha R; Bond J; Galloway G; Nayak M
    Subst Abus; 2016; 37(1):209-14. PubMed ID: 25775225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of methamphetamine dependence.
    Johnson BA; Ait-Daoud N; Elkashef AM; Smith EV; Kahn R; Vocci F; Li SH; Bloch DA;
    Int J Neuropsychopharmacol; 2008 Feb; 11(1):1-14. PubMed ID: 17470315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence.
    Rawson RA; Marinelli-Casey P; Anglin MD; Dickow A; Frazier Y; Gallagher C; Galloway GP; Herrell J; Huber A; McCann MJ; Obert J; Pennell S; Reiber C; Vandersloot D; Zweben J;
    Addiction; 2004 Jun; 99(6):708-17. PubMed ID: 15139869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of intensive motivational interviewing for methamphetamine dependence.
    Polcin DL; Bond J; Korcha R; Nayak MB; Galloway GP; Evans K
    J Addict Dis; 2014; 33(3):253-65. PubMed ID: 25115166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence.
    Longo M; Wickes W; Smout M; Harrison S; Cahill S; White JM
    Addiction; 2010 Jan; 105(1):146-54. PubMed ID: 19839966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methamphetamine treatment outcomes among gay men attending a LGBTI-specific treatment service in Sydney, Australia.
    Lea T; Kolstee J; Lambert S; Ness R; Hannan S; Holt M
    PLoS One; 2017; 12(2):e0172560. PubMed ID: 28207902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychiatric and substance dependence comorbidities, sexually transmitted diseases, and risk behaviors among methamphetamine-dependent gay and bisexual men seeking outpatient drug abuse treatment.
    Shoptaw S; Peck J; Reback CJ; Rotheram-Fuller E
    J Psychoactive Drugs; 2003 May; 35 Suppl 1():161-8. PubMed ID: 12825759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life among treatment seeking methamphetamine-dependent individuals.
    Gonzales R; Ang A; Glik DC; Rawson RA; Lee S; Iguchi MY;
    Am J Addict; 2011; 20(4):366-72. PubMed ID: 21679268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute exercise ameliorates craving and inhibitory deficits in methamphetamine: An ERP study.
    Wang D; Zhou C; Chang YK
    Physiol Behav; 2015 Aug; 147():38-46. PubMed ID: 25846839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment outcomes for methamphetamine users receiving outpatient counselling from the Stimulant Treatment Program in Australia.
    McKetin R; Dunlop AJ; Holland RM; Sutherland RA; Baker AL; Salmon AM; Hudson SL
    Drug Alcohol Rev; 2013 Jan; 32(1):80-7. PubMed ID: 22642414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bupropion for the treatment of methamphetamine dependence in non-daily users: a randomized, double-blind, placebo-controlled trial.
    Anderson AL; Li SH; Markova D; Holmes TH; Chiang N; Kahn R; Campbell J; Dickerson DL; Galloway GP; Haning W; Roache JD; Stock C; Elkashef AM
    Drug Alcohol Depend; 2015 May; 150():170-4. PubMed ID: 25818061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparisons of methamphetamine psychotic and schizophrenic symptoms: a differential item functioning analysis.
    Srisurapanont M; Arunpongpaisal S; Wada K; Marsden J; Ali R; Kongsakon R
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):959-64. PubMed ID: 21277930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
    Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R
    Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of an exercise intervention on methamphetamine use outcomes post-residential treatment care.
    Rawson RA; Chudzynski J; Mooney L; Gonzales R; Ang A; Dickerson D; Penate J; Salem BA; Dolezal B; Cooper CB
    Drug Alcohol Depend; 2015 Nov; 156():21-28. PubMed ID: 26371404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Status of methamphetamine users 2-5 years after outpatient treatment.
    Rawson RA; Huber A; Brethen P; Obert J; Gulati V; Shoptaw S; Ling W
    J Addict Dis; 2002; 21(1):107-19. PubMed ID: 11831496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LiMA: a study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence.
    Ezard N; Dunlop A; Hall M; Ali R; McKetin R; Bruno R; Phung N; Carr A; White J; Clifford B; Liu Z; Shanahan M; Dolan K; Baker AL; Lintzeris N
    BMJ Open; 2018 Jul; 8(7):e020723. PubMed ID: 30030312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men.
    Shoptaw S; Reback CJ; Peck JA; Yang X; Rotheram-Fuller E; Larkins S; Veniegas RC; Freese TE; Hucks-Ortiz C
    Drug Alcohol Depend; 2005 May; 78(2):125-34. PubMed ID: 15845315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of motivational enhancement therapy on readiness to change MDMA and methamphetamine use behaviors in Taiwanese adolescents.
    Huang YS; Tang TC; Lin CH; Yen CF
    Subst Use Misuse; 2011; 46(4):411-6. PubMed ID: 20735217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.